Mycophenolate mofetil and curcumin provide comparable therapeutic benefit in experimental chronic kidney disease: role of Nrf2-Keap1 and renal dopamine pathways-Reference-Cited by-同舟云学术

Mycophenolate mofetil and curcumin provide comparable therapeutic benefit in experimental chronic kidney disease: role of Nrf2-Keap1 and renal dopamine pathways

Published:2016-05-04 Issue:7 Volume:50 Page:781-792
ISSN:1071-5762
Container-title:Free Radical Research
language:en
Short-container-title:Free Radical Research

Author:

Tapia Edilia,García-Arroyo Fernando,Silverio Octaviano,Rodríguez-Alcocer Alma N.,Jiménez-Flores Ana B.,Cristobal Magdalena,Arellano Abraham S.,Soto Virgilia,Osorio-Alonso Horacio,Molina-Jijón Eduardo,Pedraza-Chaverri José,Sanchez-Lozada Laura G.

Funder

Consejo Nacional de Ciencia y Tecnología

Publisher

Informa UK Limited

Subject

General Medicine,Biochemistry

Link

http://www.tandfonline.com/doi/pdf/10.1080/10715762.2016.1174776

Reference45 articles.

1. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease

2. Renal microvascular dysfunction, hypertension and CKD progression

3. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats

4. Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on the role and inhibitors of Keap1 signaling pathway in inflammation;International Immunopharmacology;2024-11

2. Curcumin Prevents Renal Damage of l‐NAME Induced Hypertension in by Reducing MMP‐2 and MMP‐9;Cell Biochemistry and Function;2024-09-08

3. Potentials of curcumin against polycystic ovary syndrome: Pharmacological insights and therapeutic promises;Heliyon;2023-06

4. Protective effects of curcumin and its analogues via the Nrf2 pathway in metabolic syndrome;Current Medicinal Chemistry;2023-05-10

5. Beneficial effects of brief early life angiotensin-converting enzyme inhibition wane with time in sheep with solitary functioning kidney;Clinical Science;2023-04